L2P Research's Avatar

L2P Research

@l2plabs.bsky.social

We provide a complete array of research services as required for Investigational New Drug Applications (IND). Location: Stony Brook NY Website: https://L2PLABS.com

23 Followers  |  121 Following  |  28,194 Posts  |  Joined: 13.11.2024  |  1.5862

Latest posts by l2plabs.bsky.social on Bluesky

Preview
ZIEGLER CLOSES $44,140,000 FINANCING FRASIER (CO) CHICAGO, Nov. 2, 2025 /PRNewswire/ -- Ziegler, a specialty investment bank, is pleased to announce the successful closing of Frasier's $44,140,000 Series 2025A Bonds (the "Bonds") through the Colorado Health Facilities Authority. Frasier Meadows Manor, Inc. (Frasier) is a Colorado...
02.11.2025 15:02 — 👍 0    🔁 0    💬 0    📌 0
OncoHost to Present Two Posters Highlighting Advances in Plasma Proteomics Monitoring and Prediction for NSCLC at ISLB 2025 BINYAMINA, Israel, and CARY, N.C., Nov. 2, 2025 /PRNewswire/ -- OncoHost, a global leader in precision oncology and proteomics-based biomarker development, today announced the presentation of two new research posters at the 2025 International Society for Liquid Biopsy (ISLB) Annual...
02.11.2025 13:05 — 👍 0    🔁 0    💬 0    📌 0
Preview
FRANKLIN GRAHAM ANNOUNCES DEPLOYMENT OF EMERGENCY FIELD HOSPITAL TO BLACK RIVER, JAMAICA, IN AFTERMATH OF HURRICANE MELISSA BOONE, N.C., Nov. 1, 2025 /PRNewswire/ -- Tomorrow, Samaritan's Purse will launch its third airlift to Jamaica, scaling up the organization's ongoing relief efforts to Hurricane Melissa—the largest storm in the country's history. The 767 cargo plane will carry an Emergency Field Hospital...
01.11.2025 23:08 — 👍 0    🔁 0    💬 0    📌 0
Preview
Cryoablation plus sintilimab and lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial - Nature Cancer Wang and colleagues report the clinical results and immunological correlates of a phase 2 clinical trial of cryoablation plus lenvatinib and sintilimab in persons with advanced or metastatic intrahepatic cholangiocarcinoma.
01.11.2025 20:15 — 👍 0    🔁 0    💬 0    📌 0
Kexing Biopharm presenteert haar wereldwijde strategie en partnermogelijkheden tijdens CPHI Frankfurt 2025 FRANKFURT, Duitsland, 1 november 2025 /PRNewswire/ -- Van 28 tot 30 oktobere nam Kexing Biopharm deel aan CPHI Frankfurt 2025, een van 's werelds meest invloedrijke farmaceutische beurzen, waar haar belangrijke productenportfolio en internationale commercialiseringsoplossingen aan...
01.11.2025 20:03 — 👍 0    🔁 0    💬 0    📌 0
Kexing Biopharm präsentiert globale Strategie und Kooperationsmöglichkeiten auf der CPHI Frankfurt 2025 FRANKFURT, Deutschland, 1. November 2025 /PRNewswire/ -- Vom 28. bis 30. Oktober nahm Kexing Biopharm an der CPHI Frankfurt 2025 teil, einer der weltweit einflussreichsten Pharmamessen, und präsentierte Partnern aus globalen Märkten sein zentrales Produktportfolio und internationale...
01.11.2025 20:03 — 👍 0    🔁 0    💬 0    📌 0
Kexing Biopharm présente sa stratégie mondiale et ses opportunités de partenariat au CPHI Francfort 2025 FRANCFORT, Allemagne, 1er novembre 2025 /PRNewswire/ -- Du 28 au 30 octobre, Kexing Biopharm a participé au CPHI Francfort 2025, l'une des expositions pharmaceutiques les plus influentes au monde, présentant son portefeuille de produits clés et ses solutions de commercialisation...
01.11.2025 20:03 — 👍 0    🔁 0    💬 0    📌 0
Preview
Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma - Blood Cancer Journal
01.11.2025 17:19 — 👍 0    🔁 0    💬 0    📌 0
Preview
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical models - Nature Communications Promising clinical activity of Claudin (CLDN) 18.2-directed CAR-T cell therapy in patients with gastric cancer has been recently reported, however gastrointestinal toxicities have also been described. Here the authors recapitulate the on-target off-tumor toxicity of CLDN18.2-directed CAR-T cells due to gastric mucosa damage in preclinical models, suggesting an AND-gate strategy targeting CLDN18.2 and mesothelin to overcome CAR-T cell toxicity
01.11.2025 17:19 — 👍 0    🔁 0    💬 0    📌 0
Preview
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies - Nature Communications Claudin 18.2 (CLDN18.2) has emerged as a target for gastrointestinal cancer, however, on-target/off-tumor toxicities have been also reported. Here, after reporting evidence of erosive gastritis in patients treated with CLDN18.2 targeted immunotherapies, the authors develop and characterize CLDN18.2 fully-human VH-only single domain CARs, showing that a lower affinity CAR mitigates on-target/off-tumor toxicity while preserving anti-tumor efficacy in gastric cancer models.
01.11.2025 17:19 — 👍 0    🔁 0    💬 0    📌 0
Preview
MOASC Fosters Physician Advocates through Advocacy Award LOS ANGELES, Nov. 1, 2025 /PRNewswire/ -- The Medical Oncology Association of Southern California, Inc. (MOASC), announces the winner of the Warren Fong, MD Advocacy Award. Since its founding in 1990, MOASC has been dedicated to improving cancer care in Southern California through strong...
01.11.2025 12:06 — 👍 0    🔁 0    💬 0    📌 0
Preview
Virus-loaded patches successfully kill bacteria in contaminated food Every year, around 600 million people are struck down by foodborne illnesses. The culprits are often common yet dangerous bacteria, such as E. coli and Salmonella, that thrive in undercooked or improperly handled food. These pathogens are a particular concern in ready-to-eat (RTE) products and have caused numerous food recalls. But these widespread risks could be a thing of the past thanks to the invention of microneedle patches that inject bacteria-killing viruses into food.
01.11.2025 11:54 — 👍 0    🔁 0    💬 0    📌 0
Preview
LUNGevity Foundation Leads 2025 Lung Cancer Awareness Month to Drive Research, Awareness, and Early Detection Throughout November, LUNGevity is shining a light on the progress being made, and the work still ahead, to change the future of lung cancer WASHINGTON, Nov. 1, 2025 /PRNewswire/ -- This November, LUNGevity Foundation is leading the nation's observance of Lung Cancer Awareness Month (LCAM)...
01.11.2025 09:06 — 👍 0    🔁 0    💬 0    📌 0
Preview
Two Billion Live with Vision Impairment -- Can AI Help Prevent Sight Loss? Host C. M. (Cathy) Rubin interviews Moorfields/UCL ophthalmologist Prof. Pearse Keane, whose landmark work with Google DeepMind shows how AI can triage eye scans and speed earlier care—without replacing human judgment. NEW YORK, Nov. 1, 2025 /PRNewswire/ -- Planet Classroom's original...
01.11.2025 07:02 — 👍 0    🔁 0    💬 0    📌 0
Preview
The MedLegal Professor™ Launches #ResponsibleAILeaders Series, Honoring MedEd Cloud CEO Raji Akileh for Giving AI Its Ethical Spine CHICAGO, Nov. 1, 2025 /PRNewswire/ -- The MedLegal Professor™ (TMP), led by AI governance architect Nikki Mehrpoo , today announced the launch of the #ResponsibleAILeaders™ Series , a new initiative recognizing executives who embed enforcement-grade governance into their AI systems. The...
01.11.2025 04:16 — 👍 0    🔁 0    💬 0    📌 0
BCMP Seminar - Gary Ruvkun Armenise Amphitheater | ARM125 Thursday, April 30, 2026, 2 – 3pm Speaker Name: Gary Ruvkun Speaker Institution: MGH/HMS Genetics Seminar Title: "title TBD" Sponsor: Kevin Struhl Department/Office: Biological Chemistry and Molecular Pharmacology BCMP tags: BCMP/Cell Bio Seminar
01.11.2025 04:02 — 👍 0    🔁 0    💬 0    📌 0
Corrigendum to “The importance of education and training in neuroendocrine neoplasms: challenges and opportunities for multidisciplinary management”. [Cancer Treat. Rev. 139 (2025) 102998] The authors regret the oversight that the affiliations of Annalisa Trama and Nicola Fazio were inadvertently switched. The correct affiliations are as follows:
01.11.2025 03:18 — 👍 0    🔁 0    💬 0    📌 0
Preview
Despite Judicial Rulings, 1.5 Million Angelenos Remain at Risk: California Community Foundation Calls for Urgent Action and Long-Term Solutions LOS ANGELES, Oct. 31, 2025 /PRNewswire/ -- The potential suspension of SNAP benefits underscores the urgent need for both immediate relief capacity and sustainable solutions to food insecurity, said Miguel Santana, president and CEO of the California Community Foundation (CCF)....
01.11.2025 01:08 — 👍 0    🔁 0    💬 0    📌 0
Preview
PATRICK CARROLL INVESTS IN YOUTH WELL-BEING WITH MAJOR FIVE-YEAR COMMITMENT TO BOYS & GIRLS CLUBS OF GREATER TAMPA BAY TAMPA BAY, Fla., Oct. 31, 2025 /PRNewswire/ -- Entrepreneur and philanthropist Patrick Carroll has announced a substantial five-year commitment to the Boys & Girls Clubs of Greater Tampa Bay, reinforcing the organization's Health & Wellness Program, which supports youth mental health,...
01.11.2025 00:33 — 👍 0    🔁 0    💬 0    📌 0
Metsera Issues Statement in Response to Litigation NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer: "Metsera disagrees with the allegations in Pfizer's complaint and will address them in the...
31.10.2025 22:27 — 👍 0    🔁 0    💬 0    📌 0
Preview
KANTOR & KANTOR, LLP PROMOTES PETER S. SESSIONS TO PARTNER Longtime ERISA litigator and editor of "Your ERISA Watch" honored for leadership, excellence, and dedication to clients NORTHRIDGE, Calif., Oct. 27, 2025 /PRNewswire/ -- Kantor & Kantor, LLP proudly announces the promotion of Peter S. Sessions to Partner, recognizing his exceptional...
31.10.2025 21:10 — 👍 0    🔁 0    💬 0    📌 0
Preview
INOVIO Reports Inducement Grant Under Inducement Plan PLYMOUTH MEETING, Pa., Oct. 31, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity...
31.10.2025 20:56 — 👍 0    🔁 0    💬 0    📌 0
Preview
Otsuka ICU Medical LLC Issues Voluntary Nationwide Recall of 20 mEq Potassium Chloride Injection Due To Overwrap Mislabeled As 10 mEq Potassium Chloride Injection AUSTIN, Texas, Oct. 31, 2025 /PRNewswire/ -- Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09-30-2026 may incorrectly identify the...
31.10.2025 20:07 — 👍 0    🔁 0    💬 0    📌 0
Preview
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) ANDOVER, Mass., Oct. 31, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on October 27, 2025,...
31.10.2025 20:07 — 👍 0    🔁 0    💬 0    📌 0
Preview
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules MADISON, Wis., Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new Chief Executive Officer. As a material inducement to Mr. La Neve joining the company, and in...
31.10.2025 20:07 — 👍 0    🔁 0    💬 0    📌 0
Preview
AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND THOUSAND OAKS, Calif., Oct. 31, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the fourth quarter of 2025. The dividend will be paid on December 12, 2025, to all stockholders of record as of the close of...
31.10.2025 20:02 — 👍 0    🔁 0    💬 0    📌 0
Preview
Olympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment CENTER VALLEY, Pa., Oct. 31, 2025 /PRNewswire/ -- Olympus Corporation has announced a voluntary, global medical device corrective action to provide further clarification on the safe and effective use of bronchoscopes with laser therapy, argon plasma coagulation or high-frequency...
31.10.2025 20:02 — 👍 0    🔁 0    💬 0    📌 0
Preview
Patient Experience Grant Program Recipients Announced by The Beryl Institute Four Research Studies on Patient Experience Improvement to be Funded NASHVILLE, Tenn., Oct. 31, 2025 /PRNewswire/ -- The Beryl Institute, a global community of healthcare professionals and advocates dedicated to improving the human experience in healthcare, has announced the recipients of...
31.10.2025 19:54 — 👍 0    🔁 0    💬 0    📌 0
Preview
Foresight Psychology, PLLC, Offers Testing for GRE, MCAT, GMAT, LSAT, and ACT, and SAT Exam Accommodations Nationwide. Level the playing field and show your true potential SAN DIEGO, Oct. 31, 2025 /PRNewswire/ -- Foresight Psychology is pleased to announce the availability of psychological testing services for individuals seeking accommodations on standardized exams. We provide services for the GRE, GMAT,...
31.10.2025 19:54 — 👍 0    🔁 0    💬 0    📌 0
Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer RALEIGH, N.C., Oct. 31, 2025 /PRNewswire/ -- Preston Dermatology and Skin Surgery Center, P.A., and its founder, Dr. Sheel Desai Solomon, have swept The News & Observer's Raleigh's Best Annual Awards, announced today. Dr. Solomon earned Gold for Best Doctor, while Preston Dermatology...
31.10.2025 19:17 — 👍 0    🔁 0    💬 0    📌 0

@l2plabs is following 20 prominent accounts